Healthcare -
Biotechnology - NASDAQ - US
$ 15.88
-19.3 %
$ 1.6 B
Market Cap
-3.49
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Beam Therapeutics Inc.
| Revenue | 63.5 M |
| Cost Of Revenue | 21.9 M |
| Gross Profit | 41.6 M |
| Operating Expenses | 479 M |
| Operating Income | -416 M |
| Other Expenses | -38.8 M |
| Net Income | -377 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 63.5 | 377.7 | 60.9 | 51.8 | 24 K | 18 K | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 21.9 | 437.4 | 22.6 | 16.4 | 103.2 | 5.4 | 0.7 | 11 K |
| Gross Profit | 41.6 | (59.7) | 38.3 | 35.4 | (103.2) | (5.4) | (0.7) | 11 K |
| OPERATING INCOME | ||||||||
| Operating Expenses | 479.1 | 554.2 | 399.4 | 444.3 | 132.8 | 75.2 | 45.7 | 7.9 |
| Selling, General and Administrative Expenses | 111.5 | 116.8 | 87.8 | 57.2 | 29.6 | 20.6 | 11.9 | 2.0 |
| Research and Development Expenses | 367.6 | 437.4 | 311.6 | 387.1 | 103.2 | 54.6 | 33.9 | 5.9 |
| Operating Income | (415.6) | (176.5) | (338.5) | (392.5) | (132.8) | (75.2) | (45.7) | (7.9) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 0 | 0 | 15.3 | 9 K | 1.6 | 0.2 | 0 | 0 |
| Total Other Income | 38.9 | 45.3 | 78.3 | 21.8 | (61.8) | (3.2) | (71.0) | (0.1) |
| Pre-Tax Income | (376.7) | (131.2) | (260.2) | (370.6) | (194.6) | (78.3) | (116.7) | (8.0) |
| NET INCOME | ||||||||
| Tax Provision | 39 K | 1.4 | 3.4 | (29.3) | 61.8 | 0.1 | (71.0) | 0.5 |
| Net Income | (376.7) | (132.5) | (263.6) | (341.4) | (256.4) | (78.4) | (115.3) | (8.0) |
| EPS | 4.58 | 1.72 | 3.76 | 5.31 | 5.49 | 1.53 | 3.28 | 0.62 |